![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN (1)
02 CALCIUM OXYBATE; MAGNESIUM OXYBATE; POTASSIUM OXYBATE; SODIUM OXYBATE (1)
03 CANNABIDIOL (1)
04 CLOZAPINE (6)
05 CYTARABINE; DAUNORUBICIN (1)
06 DEFIBROTIDE SODIUM (1)
07 FLUVOXAMINE MALEATE (5)
08 LURBINECTEDIN (1)
09 SODIUM OXYBATE (1)
01 CAPSULE, EXTENDED RELEASE;ORAL (2)
02 INJECTABLE;INTRAMUSCULAR (1)
03 POWDER;INTRAVENOUS (2)
04 SOLUTION;INTRAVENOUS (1)
05 SOLUTION;ORAL (3)
06 TABLET, ORALLY DISINTEGRATING;ORAL (6)
07 TABLET; ORAL (3)
01 0.234GM/ML;0.096GM/ML;0.13GM/ML;0.04GM/ML (1)
02 0.5GM/ML (1)
03 100MG (1)
04 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (2)
05 100MG/ML (1)
06 100MG;44MG (1)
07 10MG/0.5ML (1)
08 12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
09 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (2)
10 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
11 200MG/2.5ML (80MG/ML) (1)
12 25MG (1)
13 25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
14 4MG/VIAL (1)
15 50MG (1)
16 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)
01 DISCN (8)
02 RX (6)
03 Blank (4)